ivabradine
NDC 70710-1472, ivabradine, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1472
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213442
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IVABRADINE HYDROCHLORIDE7.5 mg/1
Pharmacologic classes
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1472-6 | 70710147206 | 60 TABLET in 1 BOTTLE (70710-1472-6) |
| 70710-1472-8 | 70710147208 | 180 TABLET in 1 BOTTLE (70710-1472-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/89134202-971b-4413-a9c9-d31a5c29722bNADAC price for package 70710147206
GET /v1/drugs/nadac/70710147206
Use it
Look up 70710-1472 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1472 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1472. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.